Related Experiment Video
Updated: Mar 3, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
First-in-Man Percutaneous Transaxillary Artery Placement and Removal of the Impella 5.0 Mechanical Circulatory
Kenta Nakamura, Sandeep Krishnan, Claudius Mahr
1Division of Cardiology, Department of Medicine, Regional Heart Center, 1959 NE Pacific Street, 3rd Floor, Seattle, WA 98195 USA. jmmccabe@cardiology.washington.edu.
Abstract:
We report on the fully percutaneous insertion and removal of the Impella 5.0 microaxial flow device via the axillary artery in a patient with cardiogenic shock and peripheral artery disease. Due to inadequate iliofemoral vasculature and desire for mobility, the axillary artery was felt to be the most appropriate access approach for temporary mechanical circulatory support. The procedure was well tolerated and the patient was supported for 17 days, at which time the device was safely removed in a fully percutaneous manner at the time of permanent left ventricular assist device placement. Percutaneous transaxillary placement of the Impella 5.0 device is a feasible support option in cardiogenic shock in patients with hostile iliofemoral disease.

